美瑞健康國際(02327.HK):擬認購及收購美深威3%股份 佈局健康霧化業務
格隆匯 12 月 29日丨美瑞健康國際(02327.HK)宣佈,於2020年12月29日,公司(通過旗下全資附屬公司美瑞健康科技)與深圳美深威、其現有股東及實際控制人簽訂了有關認購深圳美深威2%股權及收購其1%股權的投資協議。
根據投資協議,美瑞健康科技將以增發的形式出資人民幣1200萬元認購深圳美深威2%的股權。另外,在該增資完成後,美瑞健康科技將以人民幣600萬元的價格受讓深圳美深威的一名現有股東所持有的深圳美深威1%股權。
據悉,深圳美深威是一家旨在全球範圍進行高品質尼古丁霧化產品研發、製造的創新性公司。董事認為全球範圍內健康霧化產品市場快速增長,市場規模非常大,集團通過入股深圳美深威,可以分享健康霧化產品行業快速發展的紅利,併為集團帶來更多元的業務以及潛在的財務收益。
近年全球範圍內健康化、減害化、電子化熱潮湧起,以低含量尼古丁、大麻二酚(CBD)等減害進而健康成分為特色的霧化行業進入高速發展快車道。作為集團大健康業務佈局特別是健康霧化業佈局的一部分,集團決定認購及收購深圳美深威部分股權,以實質性推動健康霧化業務發展。最終,集團將持有深圳美深威3%的股權。董事認為全球範圍內健康霧化產品市場快速增長,市場規模非常大,集團通過入股深圳美深威,可以分享健康霧化產品行業快速發展的紅利,併為集團帶來更多元的業務以及潛在的財務收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.